Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research
Notice Number:
NOT-DA-24-029
Key Dates
First Available Due Date:
October 12, 2024
Expiration Date:
May 08, 2027
Related Announcements
- May 19, 2021 - Summer Research Education Experience Program (R25 Clinical Trial Not Allowed). See NOFO PAR-21-168.
- August 17, 2021 - Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed). See NOFO PAR-21-271.
- September 01, 2021 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed). See NOFO PAR-21-320.
- January 26, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32). See NOFO PA-23-048.
- April 14, 2023 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed). See NOFO RFA-MH-23-331.
- August 16, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30). See NOFO PA-23-260.
- August 17, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31). See NOFO PA-23-272.
- September 07, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32). See NOFO PA-23-262.
- September 12, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity). See NOFO PA-23-271.
- November 30, 2023 - Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed). See NOFO PAR-24-048.
- February 2, 2024 - NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed). See NOFO RFA-NS-24-030.
- February 02, 2024 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required). See NOFO RFA-MH-23-330.
- April 23, 2024 - Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed). See NOFO PA-24-191.
- April 23, 2024 - Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-192.
- April 23, 2024 - NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Required). See NOFO PA-24-193.
- April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed). See NOFO PA-24-194.
- April 24, 2024 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) See NOFO PA-24-175.
- April 24, 2024 - Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-177.
- April 24, 2024 - Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Required). See NOFO PA-24-181.
- April 24, 2024 - Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Not Allowed). See NOFO PA-24-182.
- April 24, 2024 - Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-183.
- April 24, 2024 - Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required). See NOFO PA-24-190.
- April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-195.
- April 9, 2024 - Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required). See NOFO PA-24-184.
- April 09, 2024 - Mentored Patient-Oriented Research Career Development Award (Parent K23 – Independent Clinical Trial Not Allowed). See NOFO PA-24-185.
- April 09, 2024 - Mentored Patient-Oriented Research Career Development Award (Parent K23 – Independent Clinical Trial Not Allowed). See NOFO PA-24-186.
- April 09, 2024 - NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12). See NOFO PAR-24-089.
- May 8, 2024 - Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required). See NOFO PAR-24-214
- May 8, 2024- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed). See NOFO PAR-24-152
- May 12, 2024 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed). See NOFO PA-24-176.
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan, and increasing the capacity of experts in data science for biomedical research of drug addiction is critical. The purpose of this Notice is to highlight NIDAs high-priority interest in receiving applications that will support training and career development in Data Science within the overall field of drug addiction research. Grants supported under this Notice can be from individuals at formative career stages or from established investigators proposing training programs that will support early career scientists. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply. Eligible programs range from individual training programs through larger institutional grants. Examples of programs relevant to drug use and addiction training and career development include, but are not limited to:
- Development of computational tools and machine learning/artificial intelligence algorithms for analysis of a variety of existing data types on drug use and addiction, including research on the intersection of HIV/AIDS and substance use disorders.
- Analysis of large datasets, including those relevant to the prevention and treatment of substance use disorders, as well as the interactions of substance use disorders and HIV/AIDS
- Integration of different types of large datasets
- Development of databases relevant to drug addiction research, including addiction-related HIV/AIDS research
- Development of automated computational tools to standardize data to be archived in databases
Fields of Addiction Research interest include, but are not limited to:
- Genetics
- Behavioral Neuroscience
- Computational Neuroscience
- Molecular/Cellular
- Chemistry, including but not limited to medicinal chemistry
- Health Disparities
- Neuroimaging
- Epidemiology
- Health Services
- Prevention
Application and Submission Information
This notice applies to due dates on or after October 12, 2024 and subsequent receipt dates through May 8, 2027.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
- May 19, 2021 - Summer Research Education Experience Program (R25 Clinical Trial Not Allowed). See NOFO PAR-21-168.
- August 17, 2021 - Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed). See NOFO PAR-21-271.
- September 01, 2021 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed). See NOFO PAR-21-320.
- January 26, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32). See NOFO PA-23-048.
- April 14, 2023 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed). See NOFO RFA-MH-23-331.
- August 16, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30). See NOFO PA-23-260.
- August 17, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31). See NOFO PA-23-272.
- September 07, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32). See NOFO PA-23-262.
- September 12, 2023 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity). See NOFO PA-23-271.
- November 30, 2023 - Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed). See NOFO PAR-24-048.
- February 2, 2024 - NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed). See NOFO RFA-NS-24-030.
- February 02, 2024 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required). See NOFO RFA-MH-23-330.
- April 23, 2024 - Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed). See NOFO PA-24-191.
- April 23, 2024 - Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-192.
- April 23, 2024 - NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Required). See NOFO PA-24-193.
- April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed). See NOFO PA-24-194.
- April 24, 2024 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) See NOFO PA-24-175.
- April 24, 2024 - Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-177.
- April 24, 2024 - Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Required). See NOFO PA-24-181.
- April 24, 2024 - Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Not Allowed). See NOFO PA-24-182.
- April 24, 2024 - Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-183.
- April 24, 2024 - Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required). See NOFO PA-24-190.
- April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-195.
- April 9, 2024 - Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required). See NOFO PA-24-184.
- April 09, 2024 - Mentored Patient-Oriented Research Career Development Award (Parent K23 – Independent Clinical Trial Not Allowed). See NOFO PA-24-185.
- April 09, 2024 - Mentored Patient-Oriented Research Career Development Award (Parent K23 – Independent Clinical Trial Not Allowed). See NOFO PA-24-186.
- April 09, 2024 - NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12). See NOFO PAR-24-089.
- May 8, 2024 - Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required). See NOFO PAR-24-214
- May 8, 2024- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed). See NOFO PAR-24-152
- May 12, 2024 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed). See NOFO PA-24-176.
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
- For funding consideration, applicants must include NOT-DA-24-029 in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.
Inquiries
Please direct all inquiries to the contacts in Section VII of the listed notice of funding opportunity with the following additions/substitutions:
Scientific/Research Contact(s)
Susan Wright, PhD
Program Director for Big Data and Computational Science
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-6683
Email: [email protected]